<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Sequenom Inc. | Company News & Executive Profiles - SQNM | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/sequenom+inc..html]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Sequenom Inc.]]></description>
	<s:counts start="0" returned="10" found="29" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Sequenom, Inc. Q3 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-363199.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions. Your first question comes from the line of Ram Selvaraju of Hapoalim Securities. Ram Selvaraju - Hapoalim Securities A couple of financial related items, first of all, can you please give me the number of shares outstanding as of the end of the quarter, please?...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Mon, 09 Nov 2009 17:15:16 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/sequenom+inc..html"><![CDATA[Sequenom Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/ram.html"><![CDATA[RAM]]></category>
		<category domain="http://resources.bnet.com/topic/memory.html"><![CDATA[Memory]]></category>
		<category domain="http://resources.bnet.com/topic/semiconductors.html"><![CDATA[Semiconductors]]></category>
		<category domain="http://resources.bnet.com/topic/hardware.html"><![CDATA[Hardware]]></category>
		<category domain="http://resources.bnet.com/topic/components.html"><![CDATA[Components]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SQNM</category>
		<category domain="tickers">SQNM</category>
	</item>
	<item>
		<title><![CDATA[Sequenom: Heads Roll, Investors Struggle to Find the Bottom]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F164093-sequenom-heads-roll-investors-struggle-to-find-the-bottom%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Brendan Wagner submits: After an independent board investigation, Sequenom SQNM has fired arguably the three most important people in a biotech outfit - its CEO, CFO, and head of Research & Development. At the bottom of this piece is a look at attempts to peg a fair value for these...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Wed, 30 Sep 2009 06:30:54 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/cru+jones.html"><![CDATA[Cru Jones]]></category>
		<category domain="http://resources.bnet.com/topic/sequenom+inc..html"><![CDATA[Sequenom Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SQNM</category>
		<category domain="tickers">SQNM</category>
	</item>
	<item>
		<title><![CDATA[Something's Rotten in the State of Sequenom (But Who Really Cares?)]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F163845-something-s-rotten-in-the-state-of-sequenom-but-who-really-cares%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Trader Mark submits: The drama never ceases at Sequenom SQNM; there appears to be a purging of upper management after investigations into what went wrong with the company's Down Syndrome's test. [Apr 29, 2009: Sequenom Bombshell] After *that* revelation (and stock plunge from $15 to $3s) speculators have returned to...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Tue, 29 Sep 2009 01:55:38 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/tradermark.html"><![CDATA[TraderMark]]></category>
		<category domain="http://resources.bnet.com/topic/sequenom+inc..html"><![CDATA[Sequenom Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SQNM</category>
		<category domain="tickers">SQNM</category>
	</item>
	<item>
		<title><![CDATA[Sequenom Reaches Important Milestone]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F162885-sequenom-reaches-important-milestone%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Hello future.  It did not take us long to welcome the arrival of what many have expected from Sequenom SQNM and many have doubted. The expected has, indeed, begun to show, and the doubt that should disappear will stay as long as the skeptics of Wall street are ideologists...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Wed, 23 Sep 2009 12:52:32 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/prohost+biotech.html"><![CDATA[Prohost Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/sequenom+inc..html"><![CDATA[Sequenom Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SQNM</category>
		<category domain="tickers">SQNM</category>
	</item>
	<item>
		<title><![CDATA[Spectrum Pharmaceuticals, Sequenom Shares Rise on Heavy Volume]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F159335-spectrum-pharmaceuticals-sequenom-shares-rise-on-heavy-volume%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Shares of Spectrum Pharmaceuticals (NASDAQ:SPPI) jumped  on twice the average volume Monday. Shares for the biopharmaceutical company, which focuses on pioneering novel cancer therapies with a focus primarily in the areas of hematology-oncology and urology, are under a heavy accumulation which is related to Spectrum&#8217;s dealings with the FDA,...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Tue, 01 Sep 2009 02:53:07 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/m.+e.+garza.html"><![CDATA[M. E. Garza]]></category>
		<category domain="http://resources.bnet.com/topic/spectrum+pharmaceuticals+inc..html"><![CDATA[Spectrum Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sequenom+inc..html"><![CDATA[Sequenom Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SQNM</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SPPI</category>
		<category domain="tickers">SQNM,SPPI</category>
	</item>
	<item>
		<title><![CDATA[Who Sold Sequenom Last Week and Why?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F155131-who-sold-sequenom-last-week-and-why%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Sequenom&#8217;s SQNM recent stock decline looked as if a program was set for selling SQNM as soon as the financial results were announced. The point is that the firm&#8217;s financial results had nothing to do with SQNM's price move, neither during the rally that took the stock up from a...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Mon, 10 Aug 2009 08:52:47 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/prohost+biotech.html"><![CDATA[Prohost Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/sequenom+inc..html"><![CDATA[Sequenom Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SQNM</category>
		<category domain="tickers">SQNM</category>
	</item>
	<item>
		<title><![CDATA[SEQUENOM, Inc. Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-329570.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator  Operator Instructions. Harry Stylli While we wait for our question queue to be compiled or complied, I would like to take a moment to welcome a couple of new additions to our leadership team. Clinical operations are clearly an important focus for the company. I'm delighted...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Thu, 06 Aug 2009 18:52:11 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/guidance.html"><![CDATA[Guidance]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/sequenom+inc..html"><![CDATA[Sequenom Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/joe.html"><![CDATA[Joe]]></category>
		<category domain="http://resources.bnet.com/topic/team+management.html"><![CDATA[Team Management]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/operational+accounting.html"><![CDATA[Operational Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/marketing+research.html"><![CDATA[Marketing Research]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SQNM</category>
		<category domain="tickers">SQNM</category>
	</item>
	<item>
		<title><![CDATA[SEQUENOM, Inc. Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F154518-sequenom-inc-q2-2009-earnings-call-transcript%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[SEQUENOM, Inc. SQNM   Q2 2009 Earnings Call   August 6, 2009 4:30 am ET]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 06 Aug 2009 07:52:11 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/sequenom+inc..html"><![CDATA[Sequenom Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SQNM</category>
		<category domain="tickers">SQNM</category>
	</item>
	<item>
		<title><![CDATA[Sequenom and the Small Cap Biotech Bipolar Experience]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F140948-sequenom-and-the-small-cap-biotech-bipolar-experience%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Trader Mark submits: Still keeping my eye on the Sequenom SQNM, but the whole idea with this name was to avoid the small cap "biotech" bipolar experience either a huge win or a huge loss. Unfortunately, this is what this has now turned to, a coin flip. Probably the most...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Tue, 02 Jun 2009 04:33:23 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/trader+mark.html"><![CDATA[Trader Mark]]></category>
		<category domain="http://resources.bnet.com/topic/sequenom+inc..html"><![CDATA[Sequenom Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SQNM</category>
		<category domain="tickers">SQNM</category>
	</item>
	<item>
		<title><![CDATA[Sequenom, Inc. Q1 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-293942.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions. Harry Stylli Okay, operator. We are ready for the first question. Operator And your first question comes from Tony Butler with Barclays Capital. Tony Butler &#8211; Barclays Capital Thanks very much. Harry, three questions. One is what evidence do you have that the diagnostic test...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Thu, 30 Apr 2009 17:30:30 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/question.html"><![CDATA[Question]]></category>
		<category domain="http://resources.bnet.com/topic/sequenom+inc..html"><![CDATA[Sequenom Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SQNM</category>
		<category domain="tickers">SQNM</category>
	</item>
</channel>
</rss>
